Table 4 Bivariate analyses of variables in patients with and without MB.
From: Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke
Variable | MB yes (n = 140) | MB no (n = 330) | p value |
|---|---|---|---|
Age (y) | 78 (6.9) | 77.3 (6.2) | 0.34 |
Gender distribution (% men) | 45 | 43 | 0.88 |
Previous cerebral infarct | 25.7 | 20.9 | 0.058 |
Previous Intracerebral Hemorrhage | 2.9 | 0.3 | 0.006 |
Hypertension | 68.5 | 72.1 | 0.097 |
Diabetes Mellitus | 19.3 | 18.5 | 0.25 |
Hypercholesterolemia | 42.9 | 44.8 | 0.211 |
Hypertriglyceridemia | 7.1 | 6.4 | 0.34 |
Smoking | 10 | 6.7 | 0.083 |
Alcohol abuse | 1.4 | 4.8 | 0.067 |
Obesity | 19.3 | 17.6 | 0.078 |
Chronic renal failure | 8.6 | 6.1 | 0.11 |
Ischemic heart disease | 12.9 | 13.3 | 0.211 |
Peripheral vascular disease | 5.7 | 3.6 | 0.203 |
Previous Atrial Fibrillation | 51.4 | 47.3 | 0.175 |
Prior treatment with antiplatelets | 50.7 | 40 | 0.015 |
Prior treatment with statins | 42.1 | 40.6 | 0.760 |
CHA2DS2Vasc score [median (IQ range)] | 5 (4–6) | 5 (4–6) | 0.96 |
HASBLED score [median (IQ range)] | 2 (2–2) | 2 (2–2) | 0.324 |
